Eastern Bank’s Bio-Techne TECH Stock Holding History

Eastern Bank’s Portfolio TECH Stock Details TECH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.47K	Hold	35	–	–	﹤0.01%	967
2026 Q1	$1.83K	Hold	35	–	–	﹤0.01%	1005
2025 Q4	$2.06K	Buy	+35	New	+$2.13K	﹤0.01%	1024

Other funds holding TECH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Eastern Bank's TECH Position: Q2 2026 in Review

Eastern Bank held its Bio-Techne (TECH) position steady in Q2 2026 at 35 shares worth $2.47K. The position accounts for ﹤0.01% of the portfolio, ranked #967.

Eastern Bank first reported a position in TECH in Q4 2025 and has held it in 3 quarters since. 593 funds tracked by Wall St. Rank hold TECH as of Q2 2026.

Eastern Bank held 35 shares of Bio-Techne worth $2.47K as of Q2 2026.
Eastern Bank left its Bio-Techne share count unchanged in Q2 2026.
Bio-Techne made up ﹤0.01% of Eastern Bank's portfolio in Q2 2026, its #967 holding.
Eastern Bank first reported a position in Bio-Techne in Q4 2025 and has held it in 3 quarters since.
593 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2026.

Based on Eastern Bank's 13F filing for Q2 2026, filed 1 Jul 2026.